Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Association of Anticoagulant Use with Hemorrhage Location and Etiology in Spontaneous Intracerebral Hemorrhage
Cerebrovascular Disease and Interventional Neurology
S41 - Sociodemographics of Stroke and Policy in Stroke Care (1:36 PM-1:48 PM)
004

It is unclear whether anticoagulation predisposes towards lobar location of hemorrhage or whether patients with AA-ICH are more likely to have underlying CAA.

To determine whether lobar location and probable cerebral amyloid angiopathy (CAA) are more likely in anticoagulant-associated intracerebral hemorrhage (AA-ICH). 

We retrospectively assessed 844 consecutive patients with spontaneous ICH.  The Simplified Edinburgh criteria was used to assign high probability vs intermediate or low probability of CAA based on CT.  For patients who underwent brain magnetic resonance imaging (MRI) we used the Boston criteria version 2.0 to assign probable vs possible or no CAA.   

Of the 844 patients with spontaneous ICH, 33 were found to have a secondary lesion on MRI and were excluded.  Among the 811 patients with primary ICH [71±15 years, 356(44% female)], 177(22%) were associated with anticoagulation: 145(82%) with vitamin K antagonists (VKA), 27(15%) with direct oral anticoagulants (DOAC), and 5(3%) with heparin.   443(55%) patients underwent MRI of which 138(31%) had probable CAA by MRI and 60(14%) had high probability CAA by CT. Overall, 485(60%) of patients had strictly lobar ICH and 202(25%) had probable CAA by MRI or CT.   Compared to patients with non-AA-ICH, patients with AA-ICH were less likely to have lobar location of bleed (53% vs 63%, p=0.02), probable CAA by MRI or CT (28% vs 14%, p<0.0001) and probable CAA by MRI alone (34% vs 18%, p=.003).   Among patients with lobar ICH, those with AA-ICH were less likely to have probable CAA by MRI or CT (45% vs 27%, p<0.002) and probable CAA by MRI alone (43% vs 24%, p=.006) when compared to those with non-AA-ICH. 

In our study AA-ICH was inversely associated with lobar location and probable CAA.  These results suggest that anticoagulation may interact more strongly with hypertensive microangiopathy than amyloid angiopathy. These findings require replication in other cohorts.   

Authors/Disclosures
Mitchell Wilson, MD (Beth Israel Deaconess Medical Center)
PRESENTER
Dr. Wilson has nothing to disclose.
Diego Incontri, MD (Harvard Medical School / Beth Israel Deaconess Medical Center) No disclosure on file
Jia-Yi Wang, MD Dr. Wang has nothing to disclose.
Alexander Andreev, MD (BIDMC) Dr. Andreev has nothing to disclose.
Sarah Marchina No disclosure on file
Filipa Carvalho (BIDMC) No disclosure on file
Magdy H. Selim, MD, PhD (Beth Israel Deaconess Med. Ctr.) Dr. Selim has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MedRhythms Inc..
Vasileios-Arsenios Lioutas, MD (Beth Israel Deaconess Medical Center, Department of Neurology) Dr. Lioutas has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Qmetis. Dr. Lioutas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mindray. The institution of Dr. Lioutas has received research support from NIH. The institution of Dr. Lioutas has received research support from Alzheimer's Association.